Decreasing Trends in Number of Depot Medroxyprogesterone Acetate Starters in Norway - A Cross-Sectional Study

Acta Obstetricia et Gynecologica Scandinavica- United Kingdom

doi 10.1111/aogs.13262

Full Text

Abstract

Available in

Categories

Date

December 12, 2017

Authors

Ingvild Roksvaag

Finn E. Skjeldestad

Publisher

Wiley

Related search

Vaginal Atrophy Following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report

Case Reports in Obstetrics and Gynecology

English

The Effect of Depot Medroxyprogesterone Acetate on Postnatal Depression: A Randomised Controlled Trial

Journal of Family Planning and Reproductive Health Care

English

Introduction of Subcutaneous Depot Medroxyprogesterone Acetate Through Use of Community-Based Distributors in Zambia

Gates Open Research

Molecular Biology

Occupational Health

English

Randomized Clinical Trial of Self Versus Clinical Administration of Subcutaneous Depot Medroxyprogesterone Acetate

Reproductive Medicine

English

C-Reactive Protein and Lipid Profile Among Depot- Medroxyprogesterone Acetate Injections Users

Annals of the College of Medicine, Mosul

English

Commentary on ‘The Effect of Depot Medroxyprogesterone Acetate on Postnatal Depression: A Randomised Clinical Trial’

Journal of Family Planning and Reproductive Health Care

English

Depot Medroxyprogesterone Acetate Use and Periodontal Health in 15- To 44-Year-Old US Females

Journal of Periodontology

English

Does Cabergoline Help in Decreasing Chronic Pelvic Pain Due to Endometriosis Compared to Medroxyprogesterone Acetate? A Prospective Randomized Study

Journal of SAFOG

English

Differential Effects of Depot Medroxyprogesterone Acetate Administration on Vaginal Microbiome in Hispanic White and Black Women

Emerging Microbes and Infections

Infectious Diseases

English